​US puts medical device patching under the microscope

The US Food and Drug Administration (FDA) says medical device makers should take note of bug reports from external researchers and respond to security risks in a timely fashion.

The regulator published new guidelines on Wednesday detailing that manufacturers should “monitor, identify and address cybersecurity vulnerabilities and exploits” affecting medical devices that have been released to market.

The FDA has already published pre-market cyber security guidelines for network-connected medical devices and has now added non-enforceable recommendations for what manufactures should do post-market.

Network-enabled medical devices, such as some implantable defibrillators and pacemakers are, like other non-medical devices, a potential target for hackers. Medical devices differ in that they may serve a life-sustaining function and the FDA wants to ensure manufacturers have adequate processes in place to prevent and respond to weaknesses that could be exploited by attackers and lead to a malfunction of a device’s “essential clinical performance”.

The guidelines introduce tools and concepts familiar to most IT security professionals, such as the Common Vulnerability Scoring System (CVSS), which reflects on a scale of one to 10 the severity of any given flaw, based on whether it can be exploited remotely or locally, how complex an attack would need to be, and whether user interaction is required for exploitation.

It also divides medical device security into “controlled” and “uncontrolled” risks, with the latter referring to when there is an unacceptable risk that the device’s essential clinical performance could be compromised due to insufficient risk mitigations.

Reporting requirements are also addressed. The FDA generally will not need to approve software updates for devices and encourages “timely” cybersecurity risk management for marketed devices. However, it notes that manufacturers of devices that require pre-market approval should disclose the flaw in an annual report.

One example of a controlled risk is where a flaw leads to a component becoming infected by malware. So long as the “essential clinical performance” was not affected, it would not need to immediately report the weakness. However, if it was a high risk “Class III” device, the manufacturer would need to disclose details in an annual report.

Manufacturers are encouraged to report uncontrolled risks, however the FDA will not enforce reporting requirements so long as the manufacturer meets three conditions: no death is associated with the vulnerability; the manufacturer patches the issue within 30 days of learning of it and notifies users; and the manufacturer is participating in an information sharing an analysis organisation (ISAO).

One such ISAO is the US National Health Information Sharing & Analysis Center, which the FDA’s Center for Devices and Radiological Health has locked in an agreement with to encourage others to share information about medical device security and health IT infrastructure.

“All medical devices that use software and are connected to hospital and health care organizations’ networks have vulnerabilities—some we can proactively protect against, while others require vigilant monitoring and timely remediation,” said Dr Suzanne Schwartz, acting director of emergency preparedness/operations and medical countermeasures in the FDA’s Center for Devices and Radiological Health.

“The FDA is encouraging medical device manufacturers to take a proactive approach to cybersecurity management of their medical devices,” she added.

Kevin Fu, a US security researcher and one of the first experts to probe medical devices for security flaws, commended the FDA's post-market guidelines. He noted that the recommendations were difficult because they had more to do with people than technology.

But while remotely exploitable vulnerabilities are generally considered more severe than locally exploitable ones, Fu criticised the agency for limiting its analysis of infection vectors to networked devices rather than the "outcomes" of those infections.

"The final post-market guidance will need to more deliberately draw attention to outcomes of compromise and risks of vulnerabilities rather than the constantly evolving modality of delivery of exploits. After all, when we talk about surveilling for the spread of flu, we don't limit discussions to spread by cough versus spread by sneeze. Should the document list networked and connected devices as examples of infection vectors? Yes. Should it mention only networked and connected devices? No. Outcomes, not modalities."

Read more: Oracle to pour 155 fixes on top of Microsoft and Flash Patch Tuesday

Participate in CSO and Gigamon's survey on Security Priorities today!

Go into the draw for a chance to win an Apple iWatch Sports or the equivalent of $500 Visa Cashcard.

For full terms and conditions click here.

Start survey NOW!

Join the CSO newsletter!

Error: Please check your email address.

Tags National Health Information Sharing & Analysis CenterFDAFood and Drug Administration (FDA)Common Vulnerability Scoring System (CVSS)medical devicesCSO Australiacyber security

More about AppleClassCSOGigamonVisa

Show Comments

Featured Whitepapers

Editor's Recommendations

Solution Centres

Stories by Liam Tung

Latest Videos

  • 150x50

    CSO Webinar: Will your data protection strategy be enough when disaster strikes?

    Speakers: - Paul O’Connor, Engagement leader - Performance Audit Group, Victorian Auditor-General’s Office (VAGO) - Nigel Phair, Managing Director, Centre for Internet Safety - Joshua Stenhouse, Technical Evangelist, Zerto - Anthony Caruana, CSO MC & Moderator

    Play Video

  • 150x50

    CSO Webinar: The Human Factor - Your people are your biggest security weakness

    ​Speakers: David Lacey, Researcher and former CISO Royal Mail David Turner - Global Risk Management Expert Mark Guntrip - Group Manager, Email Protection, Proofpoint

    Play Video

  • 150x50

    CSO Webinar: Current ransomware defences are failing – but machine learning can drive a more proactive solution

    Speakers • Ty Miller, Director, Threat Intelligence • Mark Gregory, Leader, Network Engineering Research Group, RMIT • Jeff Lanza, Retired FBI Agent (USA) • Andy Solterbeck, VP Asia Pacific, Cylance • David Braue, CSO MC/Moderator What to expect: ​Hear from industry experts on the local and global ransomware threat landscape. Explore a new approach to dealing with ransomware using machine-learning techniques and by thinking about the problem in a fundamentally different way. Apply techniques for gathering insight into ransomware behaviour and find out what elements must go into a truly effective ransomware defence. Get a first-hand look at how ransomware actually works in practice, and how machine-learning techniques can pick up on its activities long before your employees do.

    Play Video

  • 150x50

    CSO Webinar: Get real about metadata to avoid a false sense of security

    Speakers: • Anthony Caruana – CSO MC and moderator • Ian Farquhar, Worldwide Virtual Security Team Lead, Gigamon • John Lindsay, Former CTO, iiNet • Skeeve Stevens, Futurist, Future Sumo • David Vaile - Vice chair of APF, Co-Convenor of the Cyberspace Law And Policy Community, UNSW Law Faculty This webinar covers: - A 101 on metadata - what it is and how to use it - Insight into a typical attack, what happens and what we would find when looking into the metadata - How to collect metadata, use this to detect attacks and get greater insight into how you can use this to protect your organisation - Learn how much raw data and metadata to retain and how long for - Get a reality check on how you're using your metadata and if this is enough to secure your organisation

    Play Video

  • 150x50

    CSO Webinar: How banking trojans work and how you can stop them

    CSO Webinar: How banking trojans work and how you can stop them Featuring: • John Baird, Director of Global Technology Production, Deutsche Bank • Samantha Macleod, GM Cyber Security, ME Bank • Sherrod DeGrippo, Director of Emerging Threats, Proofpoint (USA)

    Play Video

More videos

Blog Posts

Market Place